FDA Adverse Event Malfunction Summary report: N

ACCESS 2 IMMUNOASSAY SYSTEM

MDR report key: 2160986 · Received June 17, 2011

Report

Report Number
2122870-2011-01889
Event Type
Malfunction
Date Received
June 17, 2011
Date of Event
December 7, 2008
Report Date
December 8, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
JJE
PMA / PMN Number
K922823/A007
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER (FSE) WAS ONSITE ON (B)(6) 2008 TO INVESTIGATE THE EVENT. THE FSE PERFORMED A HIGH SENSITIVITY (HS) SYSTEM CHECK, LOW LEVEL QUALITY CONTROL (QC) PRECISION AND SYSTEM CHECK AND ALL PASSED WITHIN INSTRUMENT SPECS. NO HARDWARE ISSUES WERE FOUND. THE QUALITY CONTROL (QC) DATA WERE REVIEWED AND THEY WERE WITHIN SPEC PRIOR TO THE EVENT. THE SYSTEM CHECKS PERFORMED ON (B)(6) 2008 DATA WERE REVIEWED AND THEY WERE WITHIN INSTRUMENT SPECS. NO DEFINITIVE ROOT CAUSE COULD BE DETERMINED FOR THIS EVENT. THIS IS TWO OF TWO SEPARATE MDR REPORTS RELATED TO TWO PT EVENTS ASSOCIATED WITH A SINGLE MALFUNCTION REPORT ON TWO DIFFERENT DAYS. REFERENCE MDR NUMBERS: 2122870-2011-01890 FOR ALL EVENTS. THIS REPORTABLE EVENT WAS IDENTIFIED DURING RETROSPECTIVE REVIEW OF COMPLAINTS CONDUCTED BETWEEN (B)(6) 2008 AND (B)(6) 2010 FOR ADD'L REPORTABLE EVENTS.

Description of Event or Problem · 1

THE CUSTOMER CONTACTED BECKMAN COULTER, INC. (BCI) ON (B)(6) 2008 IN REGARDS TO ERRONEOUSLY ELEVATED ACCUTNI (TROPONIN) RESULTS GENERATED ON THE ACCESS 2 IMMUNOASSAY SYSTEM FOR TWO PTS. THE PT SAMPLES WERE RETESTED AND THE RESULTS WERE WITHIN THE NORMAL REFERENCE RANGE. THE INITIAL ERRONEOUSLY ELEVATED RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY. THERE ARE NO REPORTS OF ANY ADVERSE PT CONSEQUENCE OR ANY MEDICAL INTERVENTION TO PREVENT OR PRECLUDE ANY ADVERSE PT EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS 2 IMMUNOASSAY SYSTEM JJE BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 UNK ACCESS ACCUTNI